Reliability and validity of the combined heart rate and movement sensor Actiheart

被引:476
作者
Brage, S
Brage, N
Franks, PW
Ekelund, U
Wareham, NJ
机构
[1] Univ Cambridge, Inst Publ Hlth, MRC, Epidemiol Unit,Elsie Widdowson Lab, Cambridge CB1 9NL, England
[2] Univ So Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark
基金
英国惠康基金;
关键词
physical activity; heart rate variability; accelerometer; movement; walking; running; epidemiology; energy expenditure monitoring;
D O I
10.1038/sj.ejcn.1602118
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Accurate quantification of physical activity energy expenditure is a key part of the effort to understand disorders of energy metabolism. The Actiheart, a combined heart rate (HR) and movement sensor, is designed to assess physical activity in populations. Objective: To examine aspects of Actiheart reliability and validity in mechanical settings and during walking and running. Methods: In eight Actiheart units, technical reliability ( coefficients of variation, CV) and validity for movement were assessed with sinusoid accelerations (0.1-20 m/s(2)) and for HR by simulated R-wave impulses (25-250 bpm). Agreement between Actiheart and ECG was determined during rest and treadmill locomotion (3.2-12.1 km/h). Walking and running intensity (in J/min/kg) was assessed with indirect calorimetry in 11 men and nine women (26-50y, 20-29 kg/m(2)) and modelled from movement, HR, and movement+HR by multiple linear regression, adjusting for sex. Results: Median intrainstrument CV was 0.5 and 0.03% for movement and HR, respectively. Corresponding interinstrument CV values were 5.7 and 0.03% with some evidence of heteroscedasticity for movement. The linear relationship between movement and acceleration was strong (R-2=0.99, P<0.001). Simulated R-waves were detected within 1 bpm from 30 to 250 bpm. The 95% limits of agreement between Actiheart and ECG were -4.2 to 4.3 bpm. Correlations with intensity were generally high (R-2>40.84, P<0.001) but significantly highest when combining HR and movement (SEE<1 MET). Conclusions: The Actiheart is technically reliable and valid. Walking and running intensity may be estimated accurately but further studies are needed to assess validity in other activities and during free-living. Sponsorship: The study received financial support from the Wellcome Trust and SB was supported by a scholarship from Unilever, UK.
引用
收藏
页码:561 / 570
页数:10
相关论文
共 67 条
  • [41] Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women - A 20-year follow-up of the lipid research clinics prevalence study
    Mora, S
    Redberg, RF
    Cui, YD
    Whiteman, MK
    Flaws, JA
    Sharrett, AR
    Blumenthal, RS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (12): : 1600 - 1607
  • [42] Validity, reliability, and calibration of the Tritrac accelerometer as a measure of physical activity
    Nichols, JF
    Morgan, CG
    Sarkin, JA
    Sallis, JF
    Calfas, KJ
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1999, 31 (06) : 908 - 912
  • [43] PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P12
  • [44] A combined heart rate and movement sensor: proof of concept and preliminary testing study
    Rennie, K
    Rowsell, T
    Jebb, SA
    Holburn, D
    Wareham, NJ
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2000, 54 (05) : 409 - 414
  • [45] The validation of physical activity instruments for measuring energy expenditure: problems and pitfalls
    Rennie, Kirsten L.
    Wareham, Nicholas J.
    [J]. PUBLIC HEALTH NUTRITION, 1998, 1 (04) : 265 - 271
  • [46] Estimating energy expenditure by heart-rate monitoring without individual calibration
    Rennie, KL
    Hennings, SJ
    Mitchell, J
    Wareham, NJ
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2001, 33 (06) : 939 - 945
  • [47] Ideas about control of skeletal and cardiac muscle blood flow (1876-2003): cycles of revision and new vision
    Rowell, LB
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2004, 97 (01) : 384 - 392
  • [48] PHYSICAL-TRAINING AND GLUCOSE-TOLERANCE IN MIDDLE-AGED MEN WITH CHEMICAL DIABETES
    SALTIN, B
    LINDGARDE, F
    HOUSTON, M
    HORLIN, R
    NYGAARD, E
    GAD, P
    [J]. DIABETES, 1979, 28 : 30 - 32
  • [49] SEAWARD B L, 1990, Biomedical Instrumentation and Technology, V24, P37
  • [50] Sekioka Kiyotsugu, 1998, Frontiers of Medical and Biological Engineering, V8, P253